Results 41 to 50 of about 529,955 (177)
Implementation of SIJAREMAS to Reduce Maternal Mortality at Pku Muhammadiyah, Grobogan, Central Java [PDF]
Background: Maternal and Neonatal Referal Network Information System (Sistem Informasi Jejaring Rujukan Maternal dan Neonatal, SIJARIEMAS) is a program that seeks to strengthen the referral system of maternal and neonatal health in Indonesia by ...
Diah Rahayu Wulandari +9 more
core +1 more source
ABSTRACT Endometrial cancer (EC) is closely related to metabolic disorders. We aimed to investigate whether preoperative dyslipidemia independently affects the prognosis of patients with EC. One hundred and ninety‐four women diagnosed with EC by pathology and who had undergone standardized surgical treatment at the Affiliated Hospital of Jining Medical
Song Li +5 more
wiley +1 more source
Women with phenylketonuria (PKU) should maintain blood phenylalanine (phe) concentration within the recommended range before and during pregnancy to prevent maternal PKU syndrome (MPKUS) in their offspring.
Aileen Kenneson +2 more
doaj +1 more source
Maternal Phenylketonuria: Consequences of Dietary Non-Adherence and Gaps in Preconception Care-A Case Report. [PDF]
Background: Maternal phenylketonuria (PKU), a metabolic disorder caused by defective phenylalanine hydroxylase activity, requires strict lifelong dietary management to prevent toxic phenylalanine accumulation.
Donarska J, Szablewska AW, Wierzba J.
europepmc +2 more sources
Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
ABSTRACT With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential.
Shiyu Xia +11 more
wiley +1 more source
Dietetic Management of Adults with Phenylketonuria (PKU) in the UK: A Care Consensus Document.
There is an increasing number of adults and elderly patients with phenylketonuria (PKU) who are either early, late treated, or untreated. The principal treatment is a phenylalanine-restricted diet.
Charlotte Ellerton +17 more
core +1 more source
ABSTRACT Long‐chain fatty acid oxidation disorders (LC‐FAOD) are rare inherited defects of mitochondrial β‐oxidation that impair energy generation during fasting or metabolic stress. Clinical manifestations range from neonatal hypoketotic hypoglycemia and cardiomyopathy to hepatopathy, recurrent rhabdomyolysis, and chronic myopathy.
Sarah C. Grünert +37 more
wiley +1 more source
Adherence to Treatment of Phenylketonuria
Introduction: Phenylketonuria (PKU) is caused by the deficient activity of phenylalanine hydroxylase. Aim: To identify the factors associated with treatment adherence among patients with PKU seen at a southern Brazil reference center.
Tatiane Alves Vieira +5 more
doaj +1 more source
Rare Diseases in Uruguay: Focus on Infants with Abnormal Newborn Screening
Introduction: Newborn Screening Program (NBS) in Uruguay includes congenital hypothyroidism (CHT), phenylketonuria (PKU), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), medium chain acyl-CoA dehydrogenase deficiency (MCADD), and Congenital ...
Mariela Larrandaburu +8 more
doaj +1 more source
Background Individuals with phenylalanine hydroxylase (PAH) deficiency lack an enzyme needed to metabolize the amino acid, phenylalanine. This leads to an increase of phenylalanine in the blood, which is associated with changes in cognitive and ...
Tracy Brock Lowe +2 more
doaj +1 more source

